EMP-induced BBB-disruption enhances drug delivery to glioma and increases treatment efficacy in rats.

about

EMP-induced BBB-disruption enhances drug delivery to glioma and increases treatment efficacy in rats.

Item

http://www.wikidata.org/entity/Q47653500

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

EMP-induced BBB-disruption enh ...... es treatment efficacy in rats.

@en

EMP-induced BBB-disruption enh ...... es treatment efficacy in rats.

@nl

type

Item

label

EMP-induced BBB-disruption enh ...... es treatment efficacy in rats.

@en

EMP-induced BBB-disruption enh ...... es treatment efficacy in rats.

@nl

prefLabel

EMP-induced BBB-disruption enh ...... es treatment efficacy in rats.

@en

EMP-induced BBB-disruption enh ...... es treatment efficacy in rats.

@nl

P1476

EMP-induced BBB-disruption enh ...... es treatment efficacy in rats.

@en

P2093

Guirong Ding

http://www.w3.org/2001/XMLSchema#string

Guozhen Guo

http://www.w3.org/2001/XMLSchema#string

Jiajin Lin

http://www.w3.org/2001/XMLSchema#string

Kangchu Li

http://www.w3.org/2001/XMLSchema#string

Keying Zhang

http://www.w3.org/2001/XMLSchema#string

Peng Gao

http://www.w3.org/2001/XMLSchema#string

Shenglong Xu

http://www.w3.org/2001/XMLSchema#string

Xiaowu Wang

http://www.w3.org/2001/XMLSchema#string

Yan Zhou

http://www.w3.org/2001/XMLSchema#string

Yongchun Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Brain tumor stem cells: Molecular characteristics and their impact on therapy

Combining microbubbles and ultrasound for drug delivery to brain tumors: current progress and overview.

Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

Charting the course across the blood-brain barrier

Drug delivery strategies for the treatment of malignant gliomas.

Local drug delivery to the brain.

Current management of glioblastoma multiforme.

Standards of care for treatment of recurrent glioblastoma--are we there yet?

Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02

P304

60-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BEM.22090

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29105885

http://www.w3.org/2001/XMLSchema#string

P921

drug delivery